PGRMC1 and ovarian carcinoma: The sigma-2 receptor TMEM973, also shown to be associated with progesterone receptor membrane component-1 (PGRMC-1)4 is overexpressed in human malignancies, including pancreatic cancer, ovarian cancer, lung cancer, and breast cancer5–8.